Background. Recent studies have suggested that community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection is encroaching on health care settings. We describe the epidemiology of hospital-onset community-associated MRSA bloodstream infections using phenotypic and genotypic analysis.
talization, residence in a long-term care facility, or surgery during the prior year; presence of an in-dwelling catheter or percutaneous medical device; or history of MRSA infection [13] identify a third potential epidemiologic category, termed health care-associated MRSA [14] .
Molecular methods that have been used to describe MRSA strains include PFGE [15] , testing for presence of the PantonValentine leukocidin gene (PVL) [16] , and staphylococcal cassette chromosome mec (SCCmec) typing [17] , multilocus sequence typing [18] , and spa typing [19] . In addition, phenotypic rules (e.g., using antibiotic susceptibility) can be used to infer MRSA strain type [20] . Because USA300 isolates are typically susceptible to a greater number of non-b-lactam antibiotics than are traditional hospital MRSA strains, combinations of antibiotic susceptibility may provide useful information for studying the epidemiology-for example, trends over time-of CA MRSA infections [13] .
Multiple studies have described outbreaks of CA MRSA in the community or within 72 h after admission to a hospital [2, 3, 10, 21] . Recent studies have suggested that CA MRSA strains may be encroaching on nosocomial settings [22, 23] , causing infections that have onset 172 h after hospital admission. In this study, we examined whether changes in the epidemiology and rates of MRSA bloodstream infection (BSI) occurred over a 7-year period, whether prevalence of CA MRSA isolates increased among hospital-onset BSIs, and whether the outcomes of patients with hospital-onset BSIs caused by CA MRSA strains were different from those of patients infected with traditional hospital-associated strains of MRSA.
METHODS

Phenotype rule.
We updated an established algorithm that used PFGE results and antibiotic susceptibilities (MicroScan; Dade Behring) to derive phenotypic rules for predicting genotype [20] . The prior rule was based on an analysis of all genotyped MRSA BSI isolates at Stroger (formerly Cook County) Hospital (Chicago, IL). The updated phenotypic rule was derived from hospital-onset (defined as onset 172 h after hospital admission) MRSA BSI isolates that were the subject of our study. Gentoypic analyses-PFGE, PVL, and SCCmec typing-were performed, as described elsewhere [17, 24, 25 Surveillance of hospital-onset MRSA BSIs. We retrospectively studied patients hospitalized at Stroger Hospital, a 464-bed inner-city safety-net hospital in Chicago. Using electronic data, we identified patients with hospital-onset MRSA BSIs during January 2000-December 2006. The first blood culture (if obtained after 72 h into the hospitalization) was studied; any second blood culture у30 days after the first culture, during a single hospitalization, also was studied.
MRSA BSI incidence density rates for all strains, CG strains, and HG strains were measured using hospital-wide patientdays as the denominator. Intensive care unit (ICU) and non-ICU incidence density rates were measured using combined patient-days for all 7 ICUs at Stroger Hospital or non-ICU patient-days as the denominator, respectively. Patient-days for 6 months in 2003 were not available and were imputed on the basis of the patient-days in the prior and subsequent 6 months. Using all hospital-onset MRSA BSIs, we derived a yearly MRSA antibiogram to examine temporal trends in clindamycin, ciprofloxacin, and gentamicin susceptibility.
Cohort study. We evaluated risk of hospital-onset MRSA BSI due to HG strains versus CG strains. Using electronic data and chart review, we collected patient-level information, including demographic characteristics, use of immunosuppressive medications, presence of HIV infection, Charlson comorbidity score [26] , health care exposures, prior surgery, prior MRSA infection, illicit drug use, and presence of a vascular catheter. A central venous catheter was recorded as being present if it was in site any time from 3 days before until 1 day after the positive MRSA blood culture collection date; central venous catheters were classified as being "upper line" (internal jugular, subclavian, peripherally inserted central catheter) or "lower line" (femoral). BSIs were classified as being primary or secondary, as determined by established definitions; additional sites for which results of culture were positive were identified for BSIs categorized as secondary [27] . Individuals without central venous catheters but with BSIs identified as primary infections were further evaluated for the diagnosis of thrombophlebitis related to peripheral intravenous catheters.
Outcomes of all-cause in-hospital mortality, duration of bacteremia, and ICU admission were examined. Appropriate therapy was included in the analysis and was defined as treatment (if an isolate was susceptible) with vancomycin, linezolid, daptomycin, trimethoprim-sulfamethoxazole, or clindamycin. For each patient, admission to an ICU was documented both at the time of and in the week after the date the positive culture specimen was collected. Persistent BSI was defined as bacteremia for у7 days while the patient received appropriate therapy [28] .
Statistical methods. SPSS software, version 10 (SPSS), was used for statistical analysis. Categorical variables were examined with x 2 analysis, with Fisher's exact test used for small samples (i.e., if counts in у2 cells in a contingency table were !10; continuous variables were analyzed with the Student's independent-samples t test; changes over time were evaluated with the x NOTE. NT, not tested. a SCCmec analysis was not performed for 1 USA500 isolate, 3 USA300 isolates, and 1 USA600 isolate. b PVL analysis was not performed for 1 isolate. c USA300-0114 represents the strain described by Tenover et al. [16] , and the 16 isolates listed comprise the major subset of all 23 USA300 strains in our study. d These isolates did not conform to the standard PFGE designations, as described by
McDougal et al. [15] , and were not used to derive our prediction rule. analysis, each outcome of interest was modeled in a separate logistic regression model, and the inferred genotype was included as the main covariate of interest in each model. Statistically important (i.e., ) factors on univariate analysis, P ! .2 including comorbidities, demographic characteristics, days until positive culture result, and secondary sites of infection, were included in each model. Variables were removed using backward elimination of covariates with P values 1.15.
RESULTS
Phenotype rule. PFGE was performed for 66 hospital-onset MRSA BSI isolates during 2004-2006, which included a subset of 47 isolates previously studied [20] . A CA MRSA strain was identified by PFGE for 24 isolates: USA300 (23) and USA400
(1); of the USA300 isolates, 16 had the prevalent USA300-0114 PFGE pattern [16] . We classified 36 isolates as being hospitalassociated MRSA strains: USA100 (27), USA500 (5), and USA800 (4) (table 1). Six isolates (1 USA600 and 5 with genotypes of indeterminate origin) were not used to derive the prediction rule; the 6 isolates were dispersed over time.
For these 60 isolates, phenotypic analysis revealed that 2 susceptibility patterns-clindamycin susceptible and clindamycin or ciprofloxacin susceptible-were better than other phenotypic combinations at predicting a CA MRSA strain (likelihood ratio, 5.75; 95% CI, 3.39-6.89). In our subsequent analyses, we used the "clindamycin-or ciprofloxacin-susceptible rule" because of potential increased applicability.
PVL and SCCmec analyses were performed for 65 and 61 isolates, respectively. CA MRSA strains typically carried PVL and SCCmec-IV, whereas hospital-associated MRSA strains did not (table 1) . Surveillance of MRSA BSIs. Clindamycin or ciprofloxacin susceptibility was used to infer genotype of all hospital-onset MRSA BSIs from January 2000 through December 2006 (i.e., isolates susceptible to either clindamycin or ciprofloxacin were identified as CG; isolates resistant to both antibiotics were classified as HG). During this period, there were 208 isolates for 199 patients; 75 isolates were classified, using the phenotypic rule, as being CG, and 133 isolates were classified as being HG.
Over the 7 years of the study, hospital-onset MRSA BSI rates were relatively stable. When the study period was divided in half, the January figure 1) . However, the risk for hospital-onset MRSA BSIs due to CG strains increased (risk ratio, 1.9; 95% CI, 1.2-3.1;
), whereas the risk for a BSI due to HG strains decreased P p .01 (risk ratio, 0.7 95% CI, 0.46-0.93; ) (table 2) . The pro-P p .02 portion of cases due to CG doubled between the 2 time periods (24% vs. 49%). Similarly, the proportion of patients infected with CG strains in an ICU or non-ICU setting increased from period 1 to period 2 (19% to 54% and 27% to 45%, respectively).
The antibiogram for MRSA reflected the increasing number of hospital-onset MRSA BSIs due to CG strains during the study period; over time, there was a statistically significant decrease in the number of strains with clindamycin ( ), P ! .001 ciprofloxacin ( ), or gentamicin ( ) resistance P p .037 P ! .001 ( figure 2) .
Cohort study. In univariate analysis (table 3) , variables associated with hospital-onset MRSA BSIs due to HG strains included day of acquisition of positive blood culture, residence in a long-term care facility, and exposure to clindamycin, ciprofloxacin, or any antibiotic in the prior 3 months. There were no statistically significant differences between patients infected with CG and HG strains with regard to demographic characteristics, Charlson comorbidity score, other health care exposures, type of BSI (primary or secondary), or presence in the ICU when the culture was performed.
Vascular catheter use (i.e., peripheral intravenous catheter or central venous catheter) was not statistically different between patients infected with CG and HG strains. Additionally, among patients with central venous catheters, the location of the line was unimportant in assessing risk.
On multivariate analysis, only greater number of days between Hospital readmission at 3 months 20 (27) 45 (34) .284
In ICU 72 h after culture was performed 32 (43) 42 (32) .109
In ICU 1 week after culture was performed 38 (51) 55 (41 hospital admission and blood culture sample collection showed a trend toward association with HG, but the difference did not reach statistical significance (table 4) . Clinical outcomes-bacteremia duration, length of hospital stay, and hospital readmission within 3 months-were similar for patients infected with CG and HG strains. Frequency of receiving vancomycin as initial therapy was not statistically different between patients infected with CG and HG strains. Even after adjustment for comorbidities, there was no all-cause in-hospital mortality difference noted between patients infected with CG and HG strains. Patients infected with CG strains, however, did show a nonsignificant trend toward greater risk of ICU admission within 72 h after culture specimen acquisition (table 4) . For hospital-onset MRSA BSI strains that were classified as causing secondary infections, positive primary sites were most commonly the respiratory tract (73% for CG strains and 60% for HG strains; ), followed by skin and soft tissue (32% P p .194 for CG strains and 41% for HG strains;
). P p .378
DISCUSSION
To establish the epidemiology of hospital-onset MRSA BSIs at our institution, we used a phenotypic prediction rule that was based on antibiotic susceptibility results during 2000-2006. We found that the proportion of hospital-onset BSIs attributable to CG strains increased over this period (from 24% [January 2000-June 2003] to 49% [July 2003-December 2006]), whereas the overall hospital-onset MRSA BSI rate was stable. Furthermore, there does not appear to be a clustering attributable to CG strains in a particular hospital location (e.g., the proportion of infections due to CG strains increased in ICUs and in non-ICU wards). The statistically significant decrease in resistance to clindamycin, ciprofloxacin, and gentamicin among hospitalonset MRSA BSI isolates parallels the increase in number of BSIs due to CG strains.
On univariate analysis, time to culture, residence in a longterm care facility, and antibiotic exposure in the prior 3 months were predictors of infections with HG strains. After multivariate analysis, increased time to culture showed a nonsignificant trend toward association with HG isolates, suggesting exogenous infection with hospital-associated flora, whereas CG infections presenting earlier during hospitalization may reflect nosocomial infection due to endogenous CA MRSA. Although outcomes for individuals infected with CG and HG isolates were largely similar, there was a nonsignificant trend toward infections with CG strains being associated with earlier ICU admission. Cases of fulminant infections due to CA MRSA have been described [11, 29] . Although there were no mortality differences detected in our study, our ICU admission data suggest that a subset of CA MRSA strains may be more virulent than traditional hospital-associated MRSA strains.
CA MRSA strains are now a prominent cause of skin and soft-tissue infections in the community [3] . Although skin and soft-tissue infections are the predominant presentation of CA MRSA, more-invasive infections also have been seen [2, 30, 31] . In a 7.5-month study period in 2004, BSIs due to the USA300 genotype were found among both health care-associated and nosocomial BSIs in Atlanta [22] . Our study found that CA MRSA is not only an important cause of hospitalonset BSIs but also that CA MRSA has increased over the past 7 years at our hospital as a cause of these infections and may be replacing traditional hospital MRSA strains. Our results support the mathematical model of Bootsma et al. [32] that predicted-on the basis of an assumption of higher growth rate and better fitness in the community-that CA MRSA strains would replace, not add to, traditional hospital-associated MRSA strains. This replacement is in marked contrast to our experience with outpatient infections due to CA MRSA, which are occurring in addition to, rather than replacing, infections with CA methicillin-susceptible S. aureus [33] .
In addition to encroaching on nosocomial settings, the CA MRSA strains that we studied are behaving largely like their traditional hospital-associated counterparts in terms of demographic characteristics and outcomes. A study by Miller et al. [34] found that clinical and epidemiologic data could not consistently differentiate CA MRSA infection from CA methicillin-susceptible S. aureus infection among hospitalized patients. Our study suggests that, among hospital-onset MRSA BSIs, demographic data and risk factors cannot reliably distinguish patients infected with CG strains from those infected with HG strains.
The potential replacement of traditional hospital-associated MRSA strains with CA MRSA strains has several important infection-control implications. First, current guidelines are aimed at decreasing the rate of transmission of MRSA within the hospital [35, 36] ; however, the effectiveness of these interventions for controlling CA MRSA is unknown. For example, anitibiotic stewardship of fluoroquinolones has been proposed as a method for decreasing rates of MRSA infection within hospitals [37] . Although not achieving statistical significance on multivariate analysis, on univariate analysis, ciprofloxacin exposure in the 3 months before infection was a significant risk factor for an infection due to an HG strain. Fluoroquinolone use in our hospital was stable over the 7-year study period (data not shown). Further study is needed to clarify the relationship of fluoroquinolone overuse with infection due to CG strains.
Second, much is unknown regarding the colonization-toinfection pathway of CA MRSA strains. Because CA MRSA may colonize sites different from those colonized by traditional nosocomial MRSA [38] , the effectiveness of control of CG strains of interventions using nasal surveillance to identify patients for isolation and to target decolonization is unknown. Furthermore, although MRSA traditionally was thought to be an exogenous pathogen spread person to person in the hospital, it is unclear whether hospital-onset CA MRSA infections are exogenous or endogenous. Cross-transmission of CA MRSA already has been documented in both the hospital [39] and the community [40] , but improved understanding of the acquisition and transmission of CA MRSA strains is needed to direct infection-control strategies.
Our findings should be interpreted in light of study limitations. First, the study is retrospective; however, data elements used were collected prospectively in an electronic database, which enhances accuracy and completeness of data and limits recall bias. Second, antibiotic susceptibilities were used to infer genotype. Misclassification of strain type was made less likely, however, by reassessing our previously published prediction rules [20] . The applicability of the rule elsewhere depends on the local antibiogram for CA MRSA. Third, our overall hospital-onset BSI rates may have been relatively low in comparison with those of other institutions [41] , which may limit the degree to which our findings can be generalized. In addition, surveillance for nasal colonization of MRSA is not routinely performed at our hospital. Therefore, it is unknown whether changes in hospital-onset MRSA epidemiology resulted from increases in hospital cross-transmission of CA MRSA strains (i.e., exogenous infections) or increases in the number of CA MRSA-colonized patients entering the hospital (i.e., endogenous infections). Finally, although we did not detect differences in risks between patients infected with CG and HG strains, this may reflect less heterogeneity in epidemiologic risks among patients at our institution, the major safety-net hospital in our region.
Our study suggests that CA MRSA infections are encroaching on nosocomial settings and that the demographic characteristics and outcomes of patients with CG-and HG-strain hospital-onset BSIs are largely similar. Our study specifically examined BSIs; assessing whether this shift is occurring among other nosocomial infections is an area for further study. CA MRSA strains may be replacing traditional MRSA strains in the hospital, and differentiating these 2 groups with epidemiologic definitions and risk factors may become increasingly difficult. We did not determine whether CG strains colonized patients before hospital admission or were acquired while in the hospital; prospective surveillance studies will be needed to answer this question. Our findings have important implications for treatment and prevention strategies for MRSA within health care settings.
